Role for CD40-CD40 ligand interactions in the immune response to solid tumours

Molecular Immunology

Volumn 37, Issue 9, 2000, Pages 515-526

  Alexandroff, Anton B ^a   Jackson, Andrew M ^b   Paterson, T ^c   Haley, Joanne L ^a   Ross, James A ^a   Longo, D L ^d   Murphy, W J ^e   James, Keith ^a   Taub, Dennis D ^d  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e SAIC FREDERICK INC   (United States)

Author keywords

Apoptosis; Carcinoma; CD40; CD40 ligand; Melanoma; T lymphocyte

Indexed keywords

CD40 ANTIGEN; FAS LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LIGAND; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIBODY RESPONSE; ANTIGEN BINDING; APOPTOSIS; ARTICLE; BLADDER CANCER; BREAST CARCINOMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; MELANOMA CELL; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOLID TUMOR; T LYMPHOCYTE;

3T3 CELLS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD40; ANTIGENS, CD95; APOPTOSIS; BREAST NEOPLASMS; CD40 LIGAND; CELL CYCLE; CELL DIVISION; CYTOKINES; FAS LIGAND PROTEIN; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; ISOANTIGENS; K562 CELLS; MELANOMA; MEMBRANE GLYCOPROTEINS; MICE; PANCREATIC NEOPLASMS; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

ANIMALIA;

EID: 0034546367     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(00)00079-1     Document Type: Article

References (40)

1. CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface Fas ligand expression and amplifies Fas-mediated hepatocyte death during allograft rejection
2. Autocrine regulation of ICAM-1 expression on bladder cancer cell-lines: Evidence for the role of IL-1 alpha
3. Tumor immunology: False hopes-new horizons?
4. Functional CD40 ligand expression on T lymphocytes in the absence of T cell receptor engagement: Involvement in interleukin-2-induced interleukin-12 and interferon-gamma production
5. Identification of a source of biologically active CD40 ligand
6. CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8 + CTL response
7. What is the role of CD40 in cancer immunotherapy
8. CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr virus-encoded LPM1: Involvement of TRAF3 as a common mediator
9. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines
10. CD40 ligation on human cord blood CD34 + hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells
11. CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help
12. Fas ligation induces apoptosis of CD40-activated human B lymphocytes
13. A central role of CD40 ligand in the regulation of CD4 + T cell responses
14. Expression and function of CD40 on Hodgkin and Reed-Sternberg cells and the possible relevance to Hodgkin's disease
15. A novel function of CD40: Induction of cell death in transformed cells
16. Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 is mediated by the chemokine receptor CXCR4
17. Inhibition of human breast carcinoma growth by soluble recombinant human CD40 ligand
18. Role of adhesion molecules in lymphokine-activated killer cell killing of bladder cancer cells: Further evidence for a third ligand for leucocyte function-associated antigen-1
19. Expression of adhesion molecules by bladder cancer cells: Modulation by interferon-gamma and tumour necrosis factor-alpha
20. Stimulation of CD40 in human bladder carcinoma cells inhibits anti-Fas/APO-1 (CD95)-induced apoptosis
21. Engagement of CD40 antigen with soluble CD40 ligand up-regulates peptide transporter expression and restores endogenous processing functioning in Burkitt's lymphoma cells
22. Expression of functional CD40 on human osteosarcoma and Ewing's sarcoma cells
23. Protective immunity induced by tumor vaccines requires interaction between CD40 and its ligand, CD154
24. Immunostimulatory effects of a plasmid expressing CD40 ligand (CD154) on gene immunization
25. A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes
26. Accessory signalling by CD40 for T cell activation: Induction of Th1 and Th2 cytokines and synergy with interleukin-12 for interferon-gamma production
27. Control of apoptosis in Epstein Barr virus-positive nasopharyngeal carcinoma cells: Opposite effects of CD95 and CD40 stimulation
28. CD40 is a functional activation antigen and B7-independent T cell costimulatory molecule on normal human lung fibroblasts
29. CD40L is important for induction of, but not response to, costimulatory activity. ICAM-1 as the second costimulatory molecule rapidly up-regulated by CD40L
30. The many roles of CD40 in cell-mediated inflammatory response
31. Maximal proliferation of cytotoxic T lymphocytes requires reverse signalling through Fas ligand
32. The anti-human tumor effect and generation of human cytotoxic T cells in SCID mice given human peripheral blood lymphocytes by the in vivo transfer of the interleukin-6 gene using adenovirus vector
33. Induction of alloantigen-specific T cell tolerance through the treatment of T lymphocytes with wortmannin
34. Expression of the co-stimulatory molecule CD40 on melanoma cells
35. CD28:B7 interactions promote T cell adhesion
36. Resistance to cytotoxic chemotherapy induced by CD40 ligand in lymphoma cells
37. The role of Fas ligand (CD95L) in immune escape. The tumor cell strikes back
38. CD40 is a prognostic marker in primary cutaneous malignant melanoma
39. Functions of CD40 on B cells, dendritic cells and other cells
40. Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies